YOU WONT BELIEVE: 10 | Mind Blowing Facts

Hospital Epinephrine Vials Recalled Nationwide After Cracking and Leaking, with Nylon, Glass and Plastic Particles Found

American Regent recalled three lots of hospital epinephrine after cracked, leaking vials and particles including nylon, glass, and polyethylene.

Medical Daily · Sep 4

Accelerant’s Take-Private Deal Raises a Bigger Question for Insurance Stocks

Accelerant Holdings shares surged 43% after strong Q2 earnings and a Thoma Bravo take-private deal at $20.25 per share, highlighting value in specialty insurance exchange models.

MarketBeat · Sep 4

Large trade alert! Gland Pharma shares fall 3% after 1.2 crore shares change hands in 2 block deals; promoter Fosun likely seller

Gland Pharma shares fell 3% after 1.22 crore shares changed hands in two block deals worth nearly Rs 5,818 crore. Promoter Fosun Pharma Industrial was reportedly looking to sell a 5% stake for Rs 2,279.5 crore. Meanwhile, the company’s recent USFDA inspection of two Visakhapatnam facilities concluded with zero Form…

The Economic Times · Sep 4

Gland Pharma shares: Promoter Fosun Pharma likely to divest 5% equity worth Rs 2,279 crore via block deal

Fosun Pharma plans to divest 5% equity in Gland Pharma through a Rs 2,279.5 crore block deal at Rs 2,763 per share. Gland Pharma reported a 47% rise in Q1FY27 profit and operates globally, with strong R&D and growth.

The Economic Times · Sep 3

uniQure Files for US Approval of Its Huntington's Gene Therapy and Asks Regulators for Faster Review

uniQure filed for FDA approval of AMT-130, a one-time Huntington's gene therapy, and requested priority review. Here is what it means.

Medical Daily · Sep 3

Commerce Minister to inaugurate Pharma MachTech & LabNext Expo 2026 at Bharat Mandapam

Set to kick off on September 7, 2026, in Delhi, the Pharma MachTech & LabNext Expo 2026 aims to position India as a center of excellence for pharma machinery and lab equipment. During this significant event, industry pioneers and entrepreneurs will seek growth opportunities while attending various conferences discussing essential…

The Economic Times · Sep 3

Bonus issue alert! Multibagger Titan Biotech announces its maiden 1:4 bonus issue

Titan Biotech has announced its maiden 1:4 bonus issue, with one share to be issued for every four held, subject to shareholder approval. The multibagger stock has gained over 200% in a year and 100% in 2026. Here’s what investors need to know about the bonus issue and eligibility.

The Economic Times · Sep 3

Generic vs Branded Medicines in India: What Actually Changes in the Drug When You Switch

The active ingredient is the same. The rest is negotiable.Every branded drug and its generic version must contain the same active pharmaceutical ingredient at the same dosage. That is not a marketing claim, it is a legal requirement under India's Drugs and Cosmetics Act, enforced by the Central Drugs Standard…

Times Life · Sep 3

FDA Screens GLP-1 Ingredients at the Border and Warns of Vials Labeled with Pharmacies That Do Not Exist

DA has an import alert on GLP-1 ingredients with quality concerns and warns of fraudulent compounded semaglutide carrying false pharmacy names.

Medical Daily · Sep 2

Lilly’s Merida Deal Shows the GLP-1 King Is Already Thinking Beyond Obesity

Eli Lilly's $2.875 billion Merida Biosciences deal expands its immunology pipeline, as strong GLP-1 growth continues while LLY shares trail the broader health care sector.

MarketBeat · Sep 2